Blood Sample Collection for Cancer Detection
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to develop tests for early cancer detection by collecting and studying blood and tissue samples from individuals with and without cancer. By comparing these samples, researchers hope to find clues that could lead to new, earlier detection methods. The trial involves completing a questionnaire and providing blood samples, with tissue samples collected from those diagnosed with cancer. Individuals with a current cancer diagnosis, a strong suspicion of cancer, or no cancer at all, who are willing to provide blood samples, may be suitable for this trial. Participants must be able to read and understand English or Spanish.
As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could revolutionize early cancer detection.
Do I have to stop taking my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It would be best to discuss this with the study team or your doctor.
What prior data suggests that this biospecimen collection is safe?
Earlier studies have shown that collecting blood and tissue samples is safe for research. Safety measures include careful handling, storage, and quality checks to ensure proper use of the samples. Taking blood samples is usually easy for participants and involves minimal risk, similar to routine blood tests at a doctor's office.
Answering questionnaires in medical studies is also safe. These are simply a series of questions that help researchers gather important information. Overall, both collecting samples and answering questions in studies like this are considered safe and low-risk for participants.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a novel approach to early cancer detection by collecting and analyzing blood samples. Unlike traditional diagnostic methods that often rely on imaging or invasive procedures, this trial aims to identify cancer biomarkers through a simple blood test. This non-invasive method could potentially lead to earlier detection of cancer, improving treatment outcomes and patient quality of life. By comparing samples from individuals with and without cancer, researchers hope to refine tests that could become a standard tool for early diagnosis in the future.
Who Is on the Research Team?
Marie Wood, MD
Principal Investigator
University of Colorado, Denver
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants complete a questionnaire and undergo collection of blood samples at registration
Follow-up
Participants undergo collection of blood samples and possibly tissue samples at 12 months after registration
What Are the Treatments Tested in This Trial?
Interventions
- Biospecimen Collection
- Questionnaire Administration
Find a Clinic Near You
Who Is Running the Clinical Trial?
Alliance for Clinical Trials in Oncology
Lead Sponsor
National Cancer Institute (NCI)
Collaborator